Low levels of oxygen (O{2}), or hypoxia elicit profound adaptive effects on cellular metabolism macromolecular biosynthesis, proliferation, and gene expression. Most transcriptional responses to O{2} deprivation are regulated by hypoxia inducible factors (HIFs), a family of O{2} sensitive transcription factors that transactivate genes with hypoxia response elements (HREs) and their promoters are enhancers. Two highly related HIF proteins, HIF-1a, and HIF-2a regulate a large number of target genes that mediate hypoxic adaptations. Hypoxia also influences three critical pathways that coordinate intracellular metabolism growth, namely c-Myc, mTOR, and p53. Whereas HIF-1a and HIF-2a frequently regulate overlapping responses to O{2} starvation, they exhibit opposing roles in c-Myc, mTOR, and p53 regulation. We hypothesize that overlap between the HIFs and these three pathways is important to cancer cell adaptation to oxygen and nutrient withdraw. To enhance our understanding of cancer cell metabolic adaptations, we propose to: (1) define how HIF-1a and HIF-2a differentially impact c-Myc and metabolism in renal carcinoma cells, (2) characterize HIF-1a versus HIF-2a modulation of the mTOR pathway and renal carcinoma, and (3) determine if HIF-2a regulation of p53 promotes renal carcinoma progression and resistance to therapy. Cells within solid tumors frequently encounter O{2} deprivation given the poor vascular function of tumor blood vessels. The ultimate goal of this proposal is to better define hypoxic regulation of cancer cell metabolism and develop novel therapies designed to combat the unique metabolism and physiology of these lesions.

Public Health Relevance

HIFs are frequently expressed in a variety of human tumors. Information from the proposed studies will allow us to stratify patients with renal clear cell carcinoma into categories appropriate for specific targeted therapies.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-RPRB-O)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
United States
Zip Code
Li, Bo; Qiu, Bo; Lee, David S M et al. (2014) Fructose-1,6-bisphosphatase opposes renal carcinoma progression. Nature 513:251-5
Mathew, Lijoy K; Skuli, Nicolas; Mucaj, Vera et al. (2014) miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma. Proc Natl Acad Sci U S A 111:291-6
Maas, Nancy L; Singh, Nickpreet; Diehl, J Alan (2014) Generation and characterization of an analog-sensitive PERK allele. Cancer Biol Ther 15:1106-11
Fan, Jing; Ye, Jiangbin; Kamphorst, Jurre J et al. (2014) Quantitative flux analysis reveals folate-dependent NADPH production. Nature 510:298-302
Mathew, Lijoy K; Lee, Samuel S; Skuli, Nicolas et al. (2014) Restricted expression of miR-30c-2-3p and miR-30a-3p in clear cell renal cell carcinomas enhances HIF2* activity. Cancer Discov 4:53-60
Cheong, Heesun; Wu, Junmin; Gonzales, Linda K et al. (2014) Analysis of a lung defect in autophagy-deficient mouse strains. Autophagy 10:45-56
Ye, Jiangbin; Fan, Jing; Venneti, Sriram et al. (2014) Serine catabolism regulates mitochondrial redox control during hypoxia. Cancer Discov 4:1406-17
Ackerman, Daniel; Simon, M Celeste (2014) Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment. Trends Cell Biol 24:472-8
Chitnis, Nilesh; Pytel, Dariusz; Diehl, J Alan (2013) UPR-inducible miRNAs contribute to stressful situations. Trends Biochem Sci 38:447-52
Wong, Waihay J; Qiu, Bo; Nakazawa, Michael S et al. (2013) MYC degradation under low O2 tension promotes survival by evading hypoxia-induced cell death. Mol Cell Biol 33:3494-504

Showing the most recent 10 out of 52 publications